Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - SHORT-TERM INVESTMENTS
Short-term Investments CRVS - Corvus Pharmaceuticals, Inc.
14.5 M
LAST VALUE
55.70%
2 YEAR CAGR
-28.06%
5 YEAR CAGR
0.00%
10 YEAR CAGR